Skip to main navigation
Skip to search
Skip to main content
Prince Sattam bin Abdulaziz University Home
Home
Profiles
Research units
Projects
Research output
Prizes
Activities
Search by expertise, name or affiliation
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali
, Hayder M. Al-Kuraishy
, Ali I. Al-Gareeb
, Athanasios Alexiou
, Marios Papadakis
,
Ali Abdullah AlAseeri
, Mubarak Alruwaili
, Hebatallah M. Saad
, Gaber El Saber Batiha
Internal Diseases
Najran University
Al-Mustansiriyah University
Jabir Ibn Hayyan Medical University
Chandigarh University
AFNP Med
Novel Global Community Educational Foundation
Witten/Herdecke University
Al Jouf University
Matrouh University
Damanhour University
Research output
:
Contribution to journal
›
Review article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Receptor
100%
Parkinson's Disease
100%
Phosphotransferase
100%
Brain Derived Neurotrophic Factor
100%
Substantia nigra
30%
Dopaminergic Neuron
30%
Programmed Cell Death
20%
Mitochondrial Disorder
20%
Neurodegenerative Disorder
10%
Disease Severity
10%
Growth Factor
10%
Neuroscience
Brain-Derived Neurotrophic Factor
100%
Parkinson's Disease
100%
Kinase
100%
Receptor
100%
Substantia nigra
30%
Dopaminergic Neuron
30%
Programmed Cell Death
20%
Neurodegenerative Disorder
10%
Non-Motor Symptoms
10%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Brain Derived Neurotrophic Factor
100%
Parkinson's Disease
100%
Receptor
100%
Dopamine Receptor Stimulating Agent
30%
Diseases
10%
Disease Severity
10%
Growth Factor
10%